Table 1.
Description of acute COVID-19 donor cohort.
| Total (n = 89) | Mild (n = 21) | Moderate (n = 35) | Severe (n = 33) | |
|---|---|---|---|---|
| Collection Date | February–May 2020 | March–April 2020 | March–May 2020 | February–May 2020 |
| SARS-CoV-2 PCR or Antibody positivity | 100% (89/89) | 100% (21/21) | 100% (35/35) | 100% (33/33) |
| PCR+ | 100% (85/85) | 100% (18/18) | 100% (35/35) | 100% (32/32) |
| IgG+ | 96% (24/25) | 100% (5/5) | 100% (9/9) | 91% (10/11) |
| IgM+ | 81% (22/27) | 100% (11/11) | 86% (6/7) | 56% (5/9) |
| Days PSO | ||||
| Range | 0–45, | 0–33 # | 0–45 | 0–34 ## |
| (Median, IQR) | (10, 4) | (11, 4) | (11, 6) | (8, 3) |
| Gender | ||||
| Male | 58% (52/89) | 52% (11/21) | 60% (21/35) | 61% (20/33) |
| Female | 42% (37/89) | 47% (10/21) | 40% (14/35) | 39% (13/33) |
| Age (years) | ||||
| Range, | 27–98 | 27–90 | 28–98 | 53–93 * |
| (Median, IQR) | (61, 49) | (48, 39) | (59, 47) | (75, 64) |
# 14% (3/21) not reported. ## 3% (1/33) not reported. * 3% (1/33) not reported.